カテゴリ： MarketLine, スウェーデン, 企業調査

Skandinaviska Enskilda Banken AB：企業の戦略・SWOT・財務分析

◆英語タイトル：Skandinaviska Enskilda Banken AB - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3582
◆発行会社（調査会社）：MarketLine
◆発行日：2019年12月
◆ページ数：57
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スウェーデン
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Skandinaviska Enskilda Banken AB – Strategy, SWOT and Corporate Finance Report
Summary

Skandinaviska Enskilda Banken AB – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Skandinaviska Enskilda Banken AB (SEB) provides corporate and institutional banking and private and SME banking. Corporate and institutional banking offers life pension insurance, shipping and real estate financing, research and strategy, transaction services, capital markets, investment banking, asset management, venture capital, and investor services. Retail and SME banking include savings, borrowings, digital services, exchange and finance, oversea services, and wealth management. The bank serves individual, SMEs, and institutional and corporate clients through a network of branch offices, ATMs, and online portals primarily in the Nordic and Baltic regions. SEB is headquartered in Stockholm, Sweden.

Scope

- Detailed information on Skandinaviska Enskilda Banken AB required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Skandinaviska Enskilda Banken AB in the form of a SWOT analysis
- An in-depth view of the business model of Skandinaviska Enskilda Banken AB including a breakdown and examination of key business segments
- Intelligence on Skandinaviska Enskilda Banken AB’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Skandinaviska Enskilda Banken AB, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Skandinaviska Enskilda Banken AB and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Skandinaviska Enskilda Banken AB as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Skandinaviska Enskilda Banken AB’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Skandinaviska Enskilda Banken AB: Company Overview
Skandinaviska Enskilda Banken AB: Overview and Key Facts
Skandinaviska Enskilda Banken AB: Overview
Skandinaviska Enskilda Banken AB: Key Facts
Skandinaviska Enskilda Banken AB: Key Employees
Skandinaviska Enskilda Banken AB: Key Employee Biographies
Skandinaviska Enskilda Banken AB: Major Products and Services
Skandinaviska Enskilda Banken AB: Company History
Skandinaviska Enskilda Banken AB: Management Statement
Skandinaviska Enskilda Banken AB: Key Competitors
Skandinaviska Enskilda Banken AB: Company Analysis
Skandinaviska Enskilda Banken AB: Business Description
Skandinaviska Enskilda Banken AB: SWOT Analysis
Skandinaviska Enskilda Banken AB: SWOT Overview
Skandinaviska Enskilda Banken AB: Strengths
Skandinaviska Enskilda Banken AB: Weaknesses
Skandinaviska Enskilda Banken AB: Opportunities
Skandinaviska Enskilda Banken AB: Threats
Skandinaviska Enskilda Banken AB: Corporate Financial Deals Activity
Skandinaviska Enskilda Banken AB: Financial Deals Overview
Skandinaviska Enskilda Banken AB: Targets and Partners
Skandinaviska Enskilda Banken AB: Top Deals 2015 – 2019YTD*
Skandinaviska Enskilda Banken AB: Advisors
Skandinaviska Enskilda Banken AB: Top Financial Advisors
Skandinaviska Enskilda Banken AB: Mergers and Acquisitions
Skandinaviska Enskilda Banken AB: Corporate Venturing
Skandinaviska Enskilda Banken AB: Capital Raising
Skandinaviska Enskilda Banken AB: Partnership
Skandinaviska Enskilda Banken AB: Divestments
Skandinaviska Enskilda Banken AB: Recent Developments
Skandinaviska Enskilda Banken AB: News and Events Summary
Skandinaviska Enskilda Banken AB: Business Expansion
Skandinaviska Enskilda Banken AB: Contracts
Skandinaviska Enskilda Banken AB: Corporate Governance
Skandinaviska Enskilda Banken AB: Financial Deals
Skandinaviska Enskilda Banken AB: Financial Performance
Skandinaviska Enskilda Banken AB: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Skandinaviska Enskilda Banken AB: Key Facts
Table 2: Skandinaviska Enskilda Banken AB: Key Employees
Table 3: Skandinaviska Enskilda Banken AB: Company History
Table 4: Skandinaviska Enskilda Banken AB: Key Competitors
Table 5: Skandinaviska Enskilda Banken AB: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Skandinaviska Enskilda Banken AB: M&A Activity by Geography (TTM*)
Table 7: Skandinaviska Enskilda Banken AB: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Skandinaviska Enskilda Banken AB: M&A Average Deal Size - Value (US$m)
Table 9: Skandinaviska Enskilda Banken AB: Targets and Partners
Table 10: Skandinaviska Enskilda Banken AB: Top Deals 2015 - 2019YTD*
Table 11: Skandinaviska Enskilda Banken AB: Financial Advisor Ranking by Value (US$m)
Table 12: Skandinaviska Enskilda Banken AB: M&A Volume and Value Trend (2015 - YTD*2019)
Table 13: Skandinaviska Enskilda Banken AB: M&A Activity by Geography (2015 - YTD*2019)
Table 14: Skandinaviska Enskilda Banken AB: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 15: Skandinaviska Enskilda Banken AB: Corporate Venturing by Geography (2015 - YTD*2019)
Table 16: Skandinaviska Enskilda Banken AB: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 17: Skandinaviska Enskilda Banken AB: Capital Raising by Deal Type (2015 - YTD*2019)
Table 18: Skandinaviska Enskilda Banken AB: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 19: Skandinaviska Enskilda Banken AB: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 20: Skandinaviska Enskilda Banken AB: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 21: Skandinaviska Enskilda Banken AB: Divestments by Geography (2015 - YTD*2019)
Table 22: Skandinaviska Enskilda Banken AB: News and Events Summary
Table 23: Skandinaviska Enskilda Banken AB: Business Expansion
Table 24: Skandinaviska Enskilda Banken AB: Contracts
Table 25: Skandinaviska Enskilda Banken AB: Corporate Governance
Table 26: Skandinaviska Enskilda Banken AB: Financial Deals
Table 27: Skandinaviska Enskilda Banken AB: Financial Performance
Table 28: Skandinaviska Enskilda Banken AB: Strategy and Operations

★海外企業調査レポート[Skandinaviska Enskilda Banken AB：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Neuraltus Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. Neuraltus’ focuses on macrophage which …
  • Magnis Energy Technologies Ltd (MNS)：企業の財務・戦略的SWOT分析
    Magnis Energy Technologies Ltd (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Seair Inc：企業の戦略的SWOT分析
    Seair Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Innate Immunotherapeutics Ltd (IIL)-製薬・医療分野：企業M&A・提携分析
    Summary Innate Immunotherapeutics Ltd (Innate Immunotherapeutics), formerly Innate Therapeutics Ltd is a medical biotechnology company that develops therapeutic drugs for the treatment of cancer and infectious diseases. The company designs and develops immunomodulator microparticle technology. Innat …
  • Transcatheter Technologies GmbH-医療機器分野：企業M&A・提携分析
    Summary Transcatheter Technologies GmbH (Transcatheter) is a medical equipment company that develops aortic valve implantation system. The company develops technologies for self-expanding valve prostheses and endovascular stents through inner catheters. It develops aortic valve implantation system f …
  • Steris Corp-医療機器分野：企業M&A・提携分析
    Summary Steris Corp (Steris), formerly Innovative Medical Technologies, a subsidiary of Steris Plc, is a medical device company that offers infection prevention and other procedural products and services. The company offers surgical equipment and image management, sterile processing equipment, surgi …
  • Hindustan Unilever Ltd (HINDUNILVR)：企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • UGE International Ltd (UGE)：電力：M&Aディール及び事業提携情報
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company’s products include electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics, and …
  • Titan Cement Company Sa
    Titan Cement Company Sa - Strategy, SWOT and Corporate Finance Report Summary Titan Cement Company Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Alere Toxicology Plc：企業の戦略的SWOT分析
    Alere Toxicology Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Symic Biomedical Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops new therapeutics focused on matrix biology. The company’s pipeline products include SB-030 and SB-061. Its SB-030 is a clinical candidate used for the prevention of peripheral vascular diseases or vein graft …
  • WEG SA：企業の戦略・SWOT・財務分析
    WEG SA - Strategy, SWOT and Corporate Finance Report Summary WEG SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Genzyme Corp-製薬・医療分野：企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …
  • GS Yuasa Corporation：企業の戦略・SWOT・財務分析
    GS Yuasa Corporation - Strategy, SWOT and Corporate Finance Report Summary GS Yuasa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Dolby Laboratories Inc (DLB)：企業の財務・戦略的SWOT分析
    Dolby Laboratories Inc (DLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PG&E Corporation：企業の戦略・SWOT・財務情報
    PG&E Corporation - Strategy, SWOT and Corporate Finance Report Summary PG&E Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Total Produce plc：企業の戦略・SWOT・財務分析
    Total Produce plc - Strategy, SWOT and Corporate Finance Report Summary Total Produce plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Teekay Corp (TK)：石油・ガス：M&Aディール及び事業提携情報
    Summary Teekay Corp (Teekay) is a provider of marine transportation services to oil and gas industry. The company transports crude oil, liquefied natural gas (LNG), liquefied petroleum gas (LPG) and other petroleum products. It also offers offshore oil production, storage and offloading services. Te …
  • Regen BioPharma Inc (RGBP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • Lixte Biotechnology Holdings Inc (LIXT)：製薬・医療：M&Aディール及び事業提携情報
    Summary Lixte Biotechnology Holdings Inc (Lixte) is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and non-malignant diseases. It develops comprises two classes of drugs, namely, protein phosphatase inhibitors (PTase-i) designated a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆